As a trusted voice in the evolving conversation around GLP-1 medications, Ivim is committed to making America healthy again, one patient at a time
Key Features High-purity lyophilized peptide Batch-specific Certificate of Analysis included Manufactured under strict quality standards Suitable for controlled laboratory research Packaged for professional handling environments Technical Specifications Compound: BPC-157 Format: Lyophilized powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory research In-vitro studies Biochemical analysis Preclinical model research Not intended for: Human or animal use Injection, ingestion, inhalation, or topical application Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada or any regulatory authority for clinical use
503A compounded peptides are produced by licensed pharmaceutical facilities to individual prescriptions, with purity testing, sterility protocols, and regulatory oversight
Walk through gastrointestinal effects, injection site reactions, hypoglycemia, pancreatitis, and the medullary thyroid carcinoma warning
This is one of the most practical questions in metabolic medicine right now, and it deserves a straight answer rather than hype